Sam Wilks

Sam Wilks

University of Cambridge

H-index: 12

Europe-United Kingdom

About Sam Wilks

Sam Wilks, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at University of Cambridge, specializes in the field of Influenza evolution.

His recent articles reflect a diverse array of research interests and contributions to the field:

Mapping SARS-CoV-2 antigenic relationships and serological responses

Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography.

Bivalent and monovalent SARS-CoV-2 variant vaccine boosters improve coverage of the known antigenic landscape: results of the COVID-19 variant immunologic landscape (COVAIL) trial

Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera

Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolution

Influenza virus infection history shapes antibody responses to influenza vaccination

Sam Wilks Information

University

Position

___

Citations(all)

1157

Citations(since 2020)

832

Cited By

525

hIndex(all)

12

hIndex(since 2020)

12

i10Index(all)

13

i10Index(since 2020)

13

Email

University Profile Page

Google Scholar

Sam Wilks Skills & Research Interests

Influenza evolution

Top articles of Sam Wilks

Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial

Nature medicine

2023/9

Characterizing SARS-CoV-2 neutralization profiles after bivalent boosting using antigenic cartography.

2023/8/26

Direct comparison of SARS-CoV-2 variant specific neutralizing antibodies in human and hamster sera

bioRxiv

2023

Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolution

Mbio

2023/10/31

Influenza virus infection history shapes antibody responses to influenza vaccination

Nature medicine

2022/2

Analysis of SARS-CoV-2 Omicron Neutralization Data up to 2022-01-28

BioRxiv

2022/1/3

BA. 2 omicron differs immunologically from both BA. 1 omicron and pre-omicron variants (preprint)

Nature communications

2022/12/13

SARS-CoV-2 variant vaccine boosters trial: preliminary analyses

MedRxiv

2022/7/15

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

Science translational medicine

2021/11/30

Influenza virus infection history drives and shapes antibody responses to influenza vaccination

2021/6/15

See List of Professors in Sam Wilks University(University of Cambridge)